Physical development in patients with phenylketonuria on dietary treatment: a retrospective study

Mol Genet Metab. 2011 Dec;104(4):480-4. doi: 10.1016/j.ymgme.2011.08.002. Epub 2011 Aug 10.

Abstract

Objectives: To evaluate the growth and physical development in patients with phenylalanine hydroxylase deficiency who follow exclusively dietary treatment.

Methods: Anthropometric measurements of 160 patients with hyperphenylalaninemia who were followed at our center over a 25 year period were obtained. Only patients treated exclusively with a protein-restrictive diet supplemented with amino acid mixtures were included. Height, weight and body mass index were measured at birth, at diagnosis, at 6 and 12 months of age, and annually until 18 years of age in patients with phenylketonuria or until 9 years of age in patients with mild hyperphenylalaninemia and compared to official national reference values. The final height of PKU patients was also compared to their expected family height.

Results: The analysis of z scores suggested no significant differences in physical development between PKU patients and the healthy population during the study period. The final height of PKU patients revealed that they were 2 to 4 cm taller than expected when compared to the mean family height (p<0.001). The mean weight and BMI at puberty suggested that many patients with severe PKU, but not other phenotypes, were overweight during this period.

Conclusion: Physical development can be optimal in PKU patients regardless of their phenotype and the severity of the diet. A tendency to excessive weight gain is seen in adolescence in the most severe phenotypes.

MeSH terms

  • Adolescent
  • Adolescent Development*
  • Body Height
  • Body Mass Index
  • Body Weight
  • Child
  • Child Development*
  • Child, Preschool
  • Humans
  • Infant
  • Infant, Newborn
  • Obesity / etiology
  • Phenylketonurias / complications
  • Phenylketonurias / diet therapy*
  • Phenylketonurias / physiopathology
  • Retrospective Studies